Escherichia coli bacteriocins: Antimicrobial efficacy and prevalence among isolates from patients with bacteraemia

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Budič, Maruška ^a   Rijavec, Matija ^a   Petkovšek, Živa ^a   Žgur Bertok, Darja ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIOCIN; COLICIN; COLICIN E1; COLICIN E6; COLICIN E7; COLICIN K; COLICIN M; MICROCIN; SIDEROPHORE; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME INHIBITION; ESCHERICHIA COLI; GENETIC CODE; HUMAN; INNATE IMMUNITY; NONHUMAN; PHYLOGENY; PREVALENCE; URINARY TRACT INFECTION; BIOSYNTHESIS; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY;

ANTI-INFECTIVE AGENTS; BACTEREMIA; BACTERIOCINS; COLICINS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HUMANS; URINARY TRACT INFECTIONS; VIRULENCE FACTORS;

EID: 83655183714     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028769     Document Type: Article

References (51)

1. Wood AJJ, Gold HS, Moellering RC, (1996) Antimicrobial-drug resistance. N Engl J Med 335: 1445-1453.
2. Gillor O, Kirkup BC, Riley MA, (2004) Colicins and microcins: the next generation antimicrobials. In: Laskin AI, Bennett JW, M. Gadd G, editors. Adv Appl Microbiol: Academic Press pp. 129-146.
3. Riley MA, Wertz JE, (2002) Bacteriocins: evolution, ecology, and application. Annu Rev Microbiol 56: 117-137.
4. Tagg JR, Dajani AS, Wannamaker LW, (1976) Bacteriocins of gram-positive bacteria. Microbiol Mol Biol Rev 40: 722-756.
5. Gordon D, Oliver E, Littlefield-Wyer J, (2007) The Diversity of Bacteriocins in Gram-Negative Bacteria. In: Riley MA, Chavan MA, editors. Bacteriocins: Springer Berlin Heidelberg pp. 5-18.
6. Cascales E, Buchanan SK, Duché D, Kleanthous C, Lloubès R, et al. (2007) Colicin Biology. Microbiol Mol Biol Rev 71: 158-229.
7. Cao Z, Klebba PE, (2002) Mechanisms of colicin binding and transport through outer membrane porins. Biochimie 84: 399-412.
8. Duquesne S, Destoumieux-Garzon D, Peduzzi J, Rebuffat S, (2007) Microcins, gene-encoded antibacterial peptides from enterobacteria. Nat Prod Rep 24: 708-734.
9. Croxen MA, Finlay BB, (2010) Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Micro 8: 26-38.
10. Gyles CL, (1994) Escherichia coli verotoxin and other cytotoxins. In: Gyles C, editors. Escherichia coli in domestic animals and humans: CAB International, Wallingford, United Kingdom pp. 151-170.
11. Johnson JR, (1991) Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4: 80-128.
12. Rijavec M, Muller-Premru M, Zakotnik B, Zgur-Bertok D, (2008) Virulence factors and biofilm production among Escherichia coli strains causing bacteraemia of urinary tract origin. J Med Microbiol 57: 1329-1334.
13. Azpiroz MF, Poey ME, Laviña M, (2009) Microcins and urovirulence in Escherichia coli. Microb Pathog 47: 274-280.
14. Cirl C, Wieser A, Yadav M, Duerr S, Schubert S, et al. (2008) Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med 14: 399-406.
15. Bradley DE, Howard SP, Lior H, (1991) Colicinogeny of O157:H7 enterohemorrhagic Escherichia coli and the shielding of colicin and phage receptors by their O-antigenic side chains. Can J Microbiol 37: 97-104.
16. Jordi BJ, Boutaga K, van Heeswijk CM, van Knapen F, Lipman LJ, (2001) Sensitivity of Shiga toxin-producing Escherichia coli (STEC) strains for colicins under different experimental conditions. FEMS Microbiol Lett 204: 329-334.
17. Murinda S, Roberts R, Wilson R, (1996) Evaluation of colicins for inhibitory activity against diarrheagenic Escherichia coli strains, including serotype O157:H7. Appl Environ Microbiol 62: 3196-3202.
18. Patton BS, Lonergan SM, Cutler SA, Stahl CH, Dickson JS, (2008) Application of colicin E1 as a prefabrication intervention strategy. J Food Prot 71: 2519-2522.
19. Schamberger GP, Diez-Gonzalez F, (2002) Selection of recently isolated colicinogenic Escherichia coli strains inhibitory to Escherichia coli O157:H7. J Food Prot 65: 1381-1387.
20. Schamberger GP, Diez-Gonzalez F, (2004) Characterization of colicinogenic Escherichia coli strains inhibitory to enterohemorrhagic Escherichia coli. J Food Prot 67: 486-492.
21. Schamberger GP, Phillips RL, Jacobs JL, Diez-Gonzalez F, (2004) Reduction of Escherichia coli O157:H7 populations in cattle by addition of colicin E7-producing E. coli to feed. Appl Environ Microbiol 70: 6053-6060.
22. Toshima H, Hachio M, Ikemoto Y, Ogasawara J, Hase A, et al. (2007) Prevalence of enteric bacteria that inhibit growth of enterohaemorrhagic Escherichia coli O157 in humans. Epidemiol Infect 135: 110-117.
23. Stahl CH, Callaway TR, Lincoln LM, Lonergan SM, Genovese KJ, (2004) Inhibitory activities of colicins against Escherichia coli strains responsible for postweaning diarrhea and edema disease in swine. Antimicrob Agents Chemother 48: 3119-3121.
24. Cutler SA, Lonergan SM, Cornick N, Johnson AK, Stahl CH, (2007) Dietary inclusion of colicin E1 is effective in preventing postweaning diarrhea caused by F18-positive Escherichia coli in pigs. Antimicrob Agents Chemother 51: 3830-3835.
25. Trautner BW, Hull RA, Darouiche RO, (2005) Colicins prevent colonization of urinary catheters. 56: 413-415.
26. Rijavec M, Budic M, Mrak P, Muller-Premru M, Podlesek Z, et al. (2007) Prevalence of ColE1-like plasmids and colicin K production among uropathogenic Escherichia coli strains and quantification of inhibitory activity of colicin K. Appl Environ Microbiol 73: 1029-1032.
27. Patton BS, Dickson JS, Lonergan SM, Cutler SA, Stahl CH, (2007) Inhibitory activity of Colicin E1 against Listeria monocytogenes. J Food Prot 70: 1256-1262.
28. Zihler A, Le Blay G, De Wouters T, Lacroix C, Braegger C, et al. (2009) In vitro inhibition activity of different bacteriocin-producing Escherichia coli against Salmonella strains isolated from clinical cases. Lett Appl Microbiol 49: 31-38.
29. Kirkup BC, Riley MA, (2004) Antibiotic-mediated antagonism leads to a bacterial game of rock-paper-scissors in vivo. Nature 428: 412-414.
30. Grozdanov L, Raasch C, Schulze J, Sonnenborn U, Gottschalk G, et al. (2004) Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol 186: 5432-5441.
31. Poey ME, Azpiroz MF, Lavina M, (2006) Comparative analysis of chromosome-encoded microcins. Antimicrob Agents Chemother 50: 1411-1418.
32. Herzer PJ, Inouye S, Inouye M, Whittam TS, (1990) Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J Bacteriol 172: 6175-6181.
33. Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, et al. (1999) The Link between Phylogeny and Virulence in Escherichia coli Extraintestinal Infection. Infect Immun 67: 546-553.
34. Braun V, Patzer SI, Hantke K, (2002) Ton-dependent colicins and microcins: modular design and evolution. Biochimie 84: 365-380.
35. Gordon DM, O'Brien CL, (2006) Bacteriocin diversity and the frequency of multiple bacteriocin production in Escherichia coli. Microbiology 152: 3239-3244.
36. Šmajs D, Micenkova L, Šmarda J, Vrba M, Ševčikova A, et al. (2010) Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor. BMC Microbiol 10: 288.
37. Martinez JA, Soto S, Fabrega A, Almela M, Mensa J, et al. (2006) Relationship of phylogenetic background, biofilm production, and time to detection of growth in blood culture vials with clinical variables and prognosis associated with Escherichia coli bacteremia. J Clin Microbiol 44: 1468-1474.
38. Andrews SC, Robinson AK, Rodríguez-Quiñones F, (2003) Bacterial iron homeostasis. FEMS Microbiology Reviews 27: 215-237.
39. Maslow JN, Mulligan ME, Adams KS, Justis JC, Arbeit RD, (1993) Bacterial adhesins and host factors: role in the development and outcome of Escherichia coli bacteremia. Clin Infect Dis 17: 89-97.
40. Johnson JR, (1994) Pathogenesis of bacteremia during pyelonephritis. Clin Infect Dis 18: 1014-1015.
41. Johnson JR, Moseley SL, Roberts PL, Stamm WE, (1988) Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics. Infect Immun 56: 405-412.
42. Otto G, Magnusson M, Svensson M, Braconier J, Svanborg C, (2001) pap genotype and P fimbrial expression in Escherichia coli causing bacteremic and nonbacteremic febrile urinary tract infection. Clin Infect Dis 32: 1523-1531.
43. Jauréguy F, Carbonnelle E, Bonacorsi S, Clec'h C, Casassus P, et al. (2007) Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Clin Microbiol Infect 13: 854-862.
44. Johnson JR, Kuskowski MA, Gajewski A, Soto S, Horcajada JP, et al. (2005) Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. J Infect Dis 191: 46-50.
45. Zhao L, Chen X, Zhu X, Yang W, Dong L, et al. (2009) Prevalence of virulence factors and antimicrobial resistance of uropathogenic Escherichia coli in Jiangsu province (China). Urology 74: 702-707.
46. Rijavec M, Erjavec M, Avguštin J, Reissbrodt R, Fruth A, et al. (2006) High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups. Curr Microbiol 53: 158-162.
47. Cooke NM, Smith SG, Kelleher M, Rogers TR, (2010) Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates. J Clin Microbiol 48: 1099-1104.
48. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, et al. (2008) The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 61: 1024-1028.
49. Pugsley AP, (1985) Escherichia coli K12 strains for use in the identification and characterization of colicins. J Gen Microbiol 131: 369-376.
50. Raggett EM, Bainbridge G, Evans LJA, Cooper A, Lakey JH, (1998) Discovery of critical Tol A-binding residues in the bactericidal toxin colicin N: a biophysical approach. Mol Microbiol 28: 1335-1343.
51. Anderluh G, Gökçe I, Lakey JH, (2003) Expression of proteins using the third domain of the Escherichia coli periplasmic-protein TolA as a fusion partner. Protein Expr Purif 28: 173-181.